Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries

Br J Pharmacol. 2000 Jul;130(6):1191-200. doi: 10.1038/sj.bjp.0703408.

Abstract

1. In rat isolated renal artery segments contracted with 0.1 microM phenylephrine and in the presence of the NO synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME), carbachol and acetylcholine produced endothelium-dependent relaxations. The mechanisms underlying these relaxations were studied. 2. These relaxations were not affected by ODQ (1H-[1,2,4]oxadiazolo[4,3, -a]quinoxalin-1-one) or indomethacin. In arteries contracted with 20 - 30 mM K(+), L-NAME-resistant relaxations induced by carbachol and acetylcholine were virtually absent. 3. The Na(+)-K(+) ATPase inhibitor ouabain reduced these relaxations in a concentration-dependent manner. 4. In K(+)-free media, addition of K(+) (5 mM) produced 90. 5+/-3.9% (n=3) relaxation of phenylephrine-induced tone. This relaxation was endothelium-independent and ouabain-sensitive. 5. Tetraethylammonium (TEA), charybdotoxin (ChTX) and iberiotoxin (IbTX) reduced the sensitivity of carbachol-induced relaxations, but did not change the maximal response. These relaxations were not altered by 4-aminopyridine (4-AP), glibenclamide or apamin. Acetylcholine (1 microM)-induced relaxation was reduced by ChTX, but not by TEA or IbTX. 6. The cytochrome P450 inhibitor miconazole, but not 17-octadecynoic acid, reduced the sensitivity of carbachol-induced relaxations, without changing the maximal response. 7. In conclusion, in rat isolated renal arteries, acetylcholine and carbachol produced a non-NO/non-PGI(2) relaxation which is mediated by an endothelium-derived hyperpolarizing factor (EDHF). This factor does not appear to be a cytochrome P450 metabolite. The inhibition by ouabain of these relaxations suggests the possible involvement of Na(+)-K(+) ATPase activation in EDHF responses, although other mechanisms cannot be totally ruled out.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology*
  • Animals
  • Carbachol / pharmacology*
  • Charybdotoxin / pharmacology
  • Cytochrome P-450 Enzyme Inhibitors
  • Dose-Response Relationship, Drug
  • Female
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Male
  • Miconazole / pharmacology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / physiology*
  • Ouabain / pharmacology
  • Oxadiazoles / pharmacology
  • Peptides / pharmacology
  • Phenylephrine / pharmacology
  • Potassium / pharmacology
  • Potassium Channel Blockers
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Renal Artery / drug effects*
  • Renal Artery / physiology
  • Tetraethylammonium / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Cytochrome P-450 Enzyme Inhibitors
  • Oxadiazoles
  • Peptides
  • Potassium Channel Blockers
  • Quinoxalines
  • Vasoconstrictor Agents
  • Charybdotoxin
  • Phenylephrine
  • Nitric Oxide
  • Ouabain
  • Tetraethylammonium
  • iberiotoxin
  • Miconazole
  • Carbachol
  • Acetylcholine
  • Potassium
  • NG-Nitroarginine Methyl Ester
  • Indomethacin